People suffering from substance use disorder at Allegheny County Jail will now be able to access more comprehensive treatment while incarcerated.
On Wednesday, the county announced that it has opened a licensed opioid treatment medication unit, with services starting up last week. The onsite facility expands the jail's existing Opioid Use Disorder (MOUD) program by offering methadone, a medication that works to reduce reliance on opiates.
ACJ’s new medical clinic is the first of its kind in Pennsylvania — in a correctional setting or otherwise, according to the county.
"Methadone induction was the missing piece in our efforts to expand MOUD access," said Holly Martin, ACJ’s Deputy Warden for Healthcare Services in a statement. "Thanks to collaboration with our many stakeholders, we’ve now completed the puzzle."
In recent years, state officials have been working to expand medication treatment options for opioid use disorder across the criminal justice system. In 2023, Reps. Maureen Madden, D-Monroe, and Michael Schlossberg, D-Lehigh, introduced House Bill 1515, which would expand access to MOUD in all Pennsylvania jails. The bill languished in the Senate Judiciary.
Nationwide, roughly 65% of individuals who are incarcerated have an active substance use disorder, while less than 1% of prisons and jails across the country have an MOUD program to treat addiction.
Read More
While ACJ is one of 15 Pennsylvania jails that offer MOUD, it’s the only one to offer methadone induction, meaning people can start the medication at the jail without having a prior prescription.
To continue the care beyond incarceration, those using methadone will be connected with a community provider upon release, the county’s announcement said. Additionally, anyone receiving MOUD in the jail will be able to access re-entry support services through the Department of Human Services, as part of an effort to reduce the jail population and improve outcomes for people transitioning back to the community.
“Substance use disorder too often results in incarceration,” a statement from DHS Director Erin Dalton said. “If we can help people begin proven treatment while they’re in jail and continue that treatment once they return to the community, we have a real chance to help thousands of people start on the path to recovery and also reduce the high risk of fatal overdose upon release.”





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.